Inovio Biomedical Corp. (AMEX:INO)

Pure speculation play. If any one of their present immunization products works out, the company will flourish and a major impact will come about for whichever disease is effected.

Inovio has several trials going on for DNA vaccines and have already shown some great success. With insiders buying at recent 52 week lows, it appears this stock may be in for a reversal with no end in sight as it gets some fuel on its way up with inevitable phase III trials. A buyout is also possible in it's future as a partnering with Merck is already in play.

For about a year and a half I've been biting away at Inovio with short-term underperforms and doing OK. I'm changing things up a little bit in order to take score leadership away from some red-thumber with a bomb charm.

It's a struggle to find positive things to say about Inovio. They're an uninspiring vaccine developer that hasn't run a phase III trial since the failure of the SECTA electrochemical tumor ablation process in 2007. But the share price is at its lowest point since the summer 2010 market swoon and seems to have stabilized. They have early stage clinical trials of DNA vaccines for HIV, hepatitis C, and avian flu in process as well as a phase II trial of cervical cancer vaccine VGX-3100. I'm not sure their track record justifies a market cap of 100M but given the historical performance of the stock I'll make it a CAPS-only positive for now.

The drugs in the pipeline will explode this stock if they make it to market.

I think this stock has huge potential, a slow starter recently, but I think they will come alive within 2 years.

The genetic vaccines are the future, so Dr. House series use them. The hability to create very good targeted vaccine to attack only some type of disase like AIDS, Cancer and others without damaging other tissue is a dream. Just think about that: someone you know is sick with cancer, so in the labs they extract a small sample of tissue, "program" the vaccine to attack only that type of tissue, and dispense the vaccine to the person, and the immunological system is teached to destroy the bad tissue without touching anything else. Will take some time, but when approved, this company will explode like a new born star.

flu vaccine not based on old outdated viruses...uses DNA to fight viruses naturally

Once they get FDA approval, this stock should soar. Just hope that they get FDA approval...

They are or should be a part of the H1N1 ordeal and begin a turn around in the next 2 weeks possibly a few months. Depending on the severity of the H1N1 Virus.

1)AUG 1 2009 WINE FLU RESULTS CAME IN AT 100 % DEFEATED WHEN IT WAS INJECTED INTO THE PIGS..

2) AUG 5 2009 SUPPIRISE THE COMPANY HAS A PIPE LINE OF SUCCESS AS THE NEW FOR TODAY STATES THE CANCER CLINICAL STUDIES ARE ALSO
LAMDMARK RESILTS..

ITS BIOTECH TIME UNITL THE BULL MARKET APPEARS..AND THAT WONT BE FOR 1 OR 2 YEARS
UNTIL THE ELECTRIC VEHICLE IS CHEAPER AND MORE EFFECIENT...

AND THE HEALTH CARE PROBLEM IS PUT TO BED
BY MAKING THE YOUNGER AND ADLUT GENERATION HAVE MANDITORY HEALTH INSURANCE FOR BYCICLES /SKATE BOARDS ETC..

Swine Flu Pandemic is a major issue right now, not enough supply, INO is one of the few companies that has a viable vaccine that could be used to stop H1N1. Here is a recent release from Reuters:
The U.S. Health and Human Services Department declared a public health emergency over swine flu in April, giving the Food and Drug Administration the power to allow the use of unapproved medical products including adjuvants. The health department agreed to purchase more than $415 million of the vaccine additives, while saying it may not use them if enough shots are available for U.S. residents
INO also recently sold 30 million worth of shares to institutional investors for working capital, the shares were priced at 2.70/share. Current price today is 2.09. This is an easy 25-30% gain over the next week, possibly a 100% gain if we see some continued positive news about the organization.

INO is developing vacinnes against A/H1N1 and Dengue fever.

This stock was picked to outperform from May 2007 to May 2008 by TMFJbP

A hunch... :-)

TS - great new products